Abstract 11680: Impact of a Reduced Ejection Fraction on Short And Long-term Outcome in Patients With ST-elevation Myocardial Infarctions in Patients With and Without Cardiogenic Shock- Results From a German STEMI-registry

BackgroundDespite rapid percutaneous coronary interventions (PCI) impairment of left ventricular ejection fraction (LVEF) remains common in patients with acute ST-elevation myocardial infarctions (STEMI). There is few current data on prevalence of a reduced LVEF in STEMI-patients and its impact on p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A11680-A11680
Hauptverfasser: Schmucker, Johannes, Fach, Andreas, Osteresch, Rico, Retzlaff, Tina, Michel, Stephan, Garstka, Daniela, Wettwer, Tineke, Hambrecht, Rainer, Wienbergen, Harm
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundDespite rapid percutaneous coronary interventions (PCI) impairment of left ventricular ejection fraction (LVEF) remains common in patients with acute ST-elevation myocardial infarctions (STEMI). There is few current data on prevalence of a reduced LVEF in STEMI-patients and its impact on prognosis. Aim of the present study was therefore to estimate this with data from a German STEMI-registry.MethodsAll STEMI-patients treated between 2006-18 at a large german PCI-Center and documented LVEF entered analysis. Patients were stratified by initial LVEFG1>50 %, G236-50%, G3≤35 % and separated in patients with and w/o concurrent cardiogenic shock (CS).ResultsOf 5001 patients analyzed 582 (12%) presented initially with CS, while 4419 (88%) did not. When stratifying the CS-cohort by LVEF, 120 (21%) could be attributed to G1, 276 (47%) to G2 and 186 (32%) to G3. In the cohort without CS 1812 patients(41%) could be attributed to G1, 2148 (49%) to G2 and 459 (10%) to G3. A reduced LVEF was associated with higher age in both patients with CS (G161±12 yrs., G263±13 yrs., G365±14 yrs., p=0.01) and without CS (G160±13 yrs., G265±13 yrs., G368±13yrs., p
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.140.suppl_1.11680